The Hypersensitivity Reactions to Para-aminosalicylic Acid (P.A.S.)

Para-Aminosalicylic Acid: Pas

Serum concentrations of para-aminosalicylic acid (PAS) produced by various forms of PAS.

Para-aminosalicylic acid (PAS) is now generally accepted as an effective antibacterial agent in the treatment of certain forms of tuberculosis when administered alone or in combination with one of the streptomycins. However, there remains a great deal of uncertainty as to the best method of administering the drug. Both the free acid and the sodium salt of PAS have been given in various dosage f...

Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in Sprague-Dawley rats.

Para-aminosalicylic acid (PAS), an FDA-approved anti-tuberculosis drug, has been used successfully in the treatment of severe manganese (Mn)-induced Parkinsonism in humans [Jiang Y-M, Mo X-A, Du FQ, Fu X, Zhu X-Y, Gao H-Y, et al. Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study. J Occup Environ Med 2006;48:644-9]. T...

Effect of para-aminosalicylic acid (PAS) alone and in association with streptomycin on experimental ocular tuberculosis.

THE therapeutic effects of streptomycin and of para-aminosalicylic acid (PAS) in the control of many forms of experimentally induced tuberculosis and in' the treatment of clinical tuberculosis are now well known. Although streptomycin is the most powerful antituberculosis drug which has so far been fully evaluated, evidence is accumulating that a combination of streptomycin and PAS is even more...

Toleration and absorption of sodium para-aminosalicylate and para-aminosalicylic acid (neopasalate). Comparison with other forms of para-aminosalicylic acid.